Living with diabetes alongside a severe mental illness: a qualitative exploration with people with severe mental illness, family members and healthcare staff

Published date: July 2021

Additional Information: Funding Information: SLA has received funding from the Wellcome Institutional Strategic Support Fund and a National Institute of Health Research (NIHR) Clinical Trials Fellowship. SLA is a member of the Health Services & Delivery Research funding committee. SG is a deputy chair of the NIHR Health Technology Assessment (HTA) Commissioning Board, and a member of the HTA Commissioning Committee, the HTA Funding Committee Policy Group and the HTA Post‐Funding Committee teleconference. CH is a member of the NIHR HTA Commissioning Board (2015‐current). RIGH has received honoraria for speaker engagement, conference attendance or advisory boards from AstraZeneca, Boehringer‐Ingelheim, European Association for the Study of Diabetes, Eli Lilly, Janssen, Menarini, Mylan, Novo Nordisk and Omniamed, Otsuka. RIGH was a member of the HTA Prioritisation Committee C (Mental Health, Women and Children's Health) until July 2019. DS is an expert advisor to the National Institute for Health and Care Excellence (NICE) centre for guidelines and a member of the current NICE guideline development group for Rehabilitation in adults with complex psychosis and related severe mental health conditions; a Board member of the National Collaborating Centre for Mental Health (NCCMH); a Clinical Advisor (paid consultancy basis) to the National Clinical Audit of Psychosis (NCAP); these are the personal views of DS and not those of NICE, NCCMH or NCAP. DS has received personal fees from Wiley Blackwell publication ‘Promoting Recovery in Early Psychosis’ 2010, ISBN 978–1–4051–4894–8, joint editor in receipt of royalties, outside the submitted work; personal fees received as member of the current NICE guideline development group for Rehabilitation in adults with complex psychosis and related severe mental health conditions. SB, JL, CEWK, LK, TD, LH, RJ, SLP, NS and JT declare no conflicts of interest. Funding Information: This publication presents independent research funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&DR) programme (ref 15/70/26). SG, NS, SLP and RJ were also funded by the NIHR Yorkshire and Humber Applied Research Collaboration (NIHR YH‐ARC), https://www.arc‐yh.nihr.ac.uk/ . The views expressed are those of the authors and not necessarily those of the HS&DR programme, the NHS, the NIHR or the Department of Health and Social Care. Publisher Copyright: © 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Keywords: bipolar and related disorders, co-morbidity, delivery of healthcare, diabetes mellitus, schizophrenia spectrum and other psychotic disorders, self management

Local EPrints ID: 447876

URI: http://eprints.soton.ac.uk/id/eprint/447876

DOI: doi:10.1111/dme.14562

ISSN: 0742-3071

PURE UUID: 31326b4d-a2dd-4f8f-812e-16ca35661259

ORCID for Richard Holt: orcid.org/0000-0001-8911-6744

Date deposited: 25 Mar 2021 18:19

Last modified: 17 Mar 2024 06:26